News for Healthier Living

Liquid Biopsy Predicts Response to Breast Cancer Immunotherapy

Immunotherapy has become a standard of care in treating high-risk, early-stage breast cancers, yet it has had limited success in shrinking tumors. New biomarkers that can improve outcomes for patients are urgently needed.

April 30, 2026


May 1 2026

April 30 2026

April 29 2026

April 28 2026

April 27 2026

April 26 2026

April 25 2026

April 24 2026

April 23 2026

April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026

April 17 2026